Free accessReview articleFirst published online 2011-1
Context-Specific Growth Hormone Signaling through the Transcription Factor STAT5: Implications for the Etiology of Hepatosteatosis and Hepatocellular Carcinoma
Growth hormone (GH) controls hepatic physiology to a large extent through the transcription factor signal transducers and activators of transcription (STAT) 5. Here, we focus on lessons learned from the physiology and pathophysiology of mice with disrupted Ghr and Stat5 loci. We discuss that hepatosteatosis and hepatocellular carcinoma observed in the absence of STAT5 can be explained in part through an aberrant activation of STAT1 and STAT3, which in themselves promote cell proliferation and survival. We also argue that STAT5 can be a context-specific tumor suppressor as it negatively regulates cell cycle progression. Lastly, we discuss promiscuity between STAT members that permits a given cytokine receptor to activate different STATs and thereby elicit context-dependent biological responses.
Barclay JL,Kerr LM,Arthur L, et al.In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.Mol Endocrinol. 2010;24:204-17
2.
Barclay JL,Nelson CN,Ishikawa M, et al.GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.Endocrinology. 2011;152:181-92
3.
Rowland JE,Kerr LM,White M,Noakes PG,Waters MJ.Heterozygote effects in mice with partial truncations in the growth hormone receptor cytoplasmic domain: assessment of growth parameters and phenotype.Endocrinology. 2005;146:5278-86
4.
Rowland JE,Lichanska AM,Kerr LM, et al.In vivo analysis of growth hormone receptor signaling domains and their associated transcripts.Mol Cell Biol. 2005;25:66-77
5.
Zhou Y,Xu BC,Maheshwari HG, et al.A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).Proc Natl Acad Sci U S A. 1997;94:13215-20
6.
Fan Y,Menon RK,Cohen P, et al.Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.J Biol Chem. 2009;284:19937-44
7.
Cui Y,Hosui A,Sun R, et al.Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration.Hepatology. 2007;46:504-13
8.
Udy GB,Towers RP,Snell RG, et al.Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.Proc Natl Acad Sci U S A. 1997;94:7239-44
9.
Clodfelter KH,Holloway MG,Hodor P,Park SH,Ray WJ,Waxman DJ.Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis.Mol Endocrinol. 2006;20:1333-51
10.
Clodfelter KH,Miles GD,Wauthier V, et al.Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.Physiol Genomics. 2007;31:63-74
11.
Holloway MG,Cui Y,Laz EV,Hosui A,Hennighausen L,Waxman DJ.Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus.Endocrinology. 2007;148:1977-86
12.
Liu X,Robinson GW,Wagner KU,Garrett L,Wynshaw-Boris A,Hennighausen L.Stat5a is mandatory for adult mammary gland development and lactogenesis.Genes Dev. 1997;11:179-86
13.
Cui Y,Riedlinger G,Miyoshi K, et al.Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.Mol Cell Biol. 2004;24:8037-47
14.
Engblom D,Kornfeld JW,Schwake L, et al.Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression.Genes Dev. 2007;21:1157-62
15.
Takahashi Y,Iida K,Takahashi K, et al.Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency.Gastroenterology. 2007;132:938-43
16.
Laron Z,Ginsberg S,Webb M.Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion: preliminary report.Growth Horm IGF Res. 2008;18:434-8
17.
Hosui A,Kimura A,Yamaji D,Zhu BM,Na R,Hennighausen L.Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation.J Exp Med. 2009;206:819-31
18.
Blaas L,Kornfeld JW,Schramek D, et al.Disruption of the growth hormone–signal transducer and activator of transcription 5–insulin like growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.Hepatology. 2010;51:1319-26
19.
Yu S,Matsusue K,Kashireddy P, et al.Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) over expression.J Biol Chem. 2003;278:498-505
20.
Matsusue K,Haluzik M,Lambert G, et al.Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.J Clin Invest. 2003;111:737-47
21.
Gavrilova O,Haluzik M,Matsusue K, et al.Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.J Biol Chem. 2003;278:34268-76
22.
Sachithanandan N,Fam BC,Fynch S, et al.Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.Hepatology. 2010;52:1632-42
23.
Wierenga AT,Vellenga E,Schuringa JJ.Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels.Mol Cell Biol. 2008;28:6668-80
24.
Hoelbl A,Schuster C,Kovacic B, et al.Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia.EMBO Mol Med. 2010;2:98-110
25.
Vafaizadeh V,Klemmt P,Brendel C, et al.Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.Stem Cells. 2010;28:928-38
26.
Miermont AM,Parrish AR,Furth PA.Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.Carcinogenesis. 2010;31:1124-31
27.
Humphreys RC,Hennighausen L.Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis.Cell Growth Differ. 1999;10:685-94
28.
Humphreys RC,Hennighausen L.Transforming growth factor alpha and mouse models of human breast cancer.Oncogene. 2000;19:1085-91
29.
Tan SH,Dagvadorj A,Shen F, et al.Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.Cancer Res. 2008;68:236-48
30.
Yu JH,Zhu BM,Wickre M, et al.The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expression.Hepatology. 2010;52:1808-18
31.
Ogata H,Kobayashi T,Chinen T, et al.Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.Gastroenterology. 2006;131:179-93
32.
Ogata H,Chinen T,Yoshida T, et al.Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.Oncogene. 2006;25:2520-30
33.
He G,Yu GY,Temkin V, et al.Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.Cancer Cell. 2010;17:286-97
34.
Park JH,Adoro S,Guinter T, et al.Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells.Nat Immunol. 2010;11:257-64
35.
Niwa Y,Kanda H,Shikauchi Y, et al.Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.Oncogene. 2005;24:6406-17
36.
Elliott J.SOCS3 in liver regeneration and hepatocarcinoma.Mol Interv. 2008;1:19-21
37.
Riehle KJ,Campbell JS,McMahan RS, et al.Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.J Exp Med. 2008;205:91-103
